Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

被引:243
|
作者
Vogelzangs, N. [1 ,2 ]
Duivis, H. E. [3 ]
Beekman, A. T. F. [1 ,2 ]
Kluft, C. [4 ]
Neuteboom, J. [4 ]
Hoogendijk, W. [5 ]
Smit, J. H. [1 ,2 ]
de Jonge, P. [6 ]
Penninx, B. W. J. H. [1 ,2 ,6 ,7 ,8 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, NL-1081 HL Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, NL-1081 HL Amsterdam, Netherlands
[3] Tilburg Univ, Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands
[4] Good Biomarker Sci, Leiden, Netherlands
[5] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands
[6] Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands
[7] Leiden Univ Med Ctr, Dept Psychiat, Leiden, Netherlands
[8] Vrije Univ Amsterdam Med Ctr, NL-1081 HL Amsterdam, Netherlands
来源
关键词
antidepressants; cohort study; depression characteristics; depressive disorder; inflammation; PITUITARY-ADRENAL AXIS; MAJOR DEPRESSION; TREATMENT RESPONSE; METABOLIC SYNDROME; HEALTH BEHAVIORS; SEX-DIFFERENCES; CYTOKINES; ANXIETY; RISK; INTERLEUKIN-6;
D O I
10.1038/tp.2012.8
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Growing evidence suggests that immune dysregulation may be involved in depressive disorders, but the exact nature of this association is still unknown and may be restricted to specific subgroups. This study examines the association between depressive disorders, depression characteristics and antidepressant medication with inflammation in a large cohort of controls and depressed persons, taking possible sex differences and important confounding factors into account. Persons (18-65 years) with a current (N = 1132) or remitted (N = 789) depressive disorder according to DSM-IV criteria and healthy controls (N = 494) were selected from the Netherlands Study of Depression and Anxiety. Assessments included clinical characteristics (severity, duration and age of onset), use of antidepressant medication and inflammatory markers (C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha)). After adjustment for sociodemographics, currently depressed men, but not women, had higher levels of CRP (1.33 versus 0.92 mg l(-1), P<0.001, Cohen's d = 0.32) and IL-6 (0.88 versus 0.72 pg ml(-1), P = 0.01, Cohen's d = 0.23) than non-depressed peers. Associations reduced after considering lifestyle and disease indicators - especially body mass index - but remained significant for CRP. After full adjustment, highest inflammation levels were found in depressed men with an older age of depression onset (CRP, TNF-alpha). Furthermore, inflammation was increased in men using serotonin-norepinephrine reuptake inhibitors (CRP, IL-6) and in men and women using tri- or tetracyclic antidepressants (CRP), but decreased among men using selective serotonin reuptake inhibitors (IL-6). In conclusion, elevated inflammation was confirmed in depressed men, especially those with a late-onset depression. Specific antidepressants may differ in their effects on inflammation. Translational Psychiatry (2012) 2, e79; doi:10.1038/tp.2012.8; published online 21 February 2012
引用
收藏
页码:e79 / e79
页数:9
相关论文
共 50 条
  • [1] Association of depressive disorders, depression characteristics and antidepressant medication with inflammation
    N Vogelzangs
    H E Duivis
    A T F Beekman
    C Kluft
    J Neuteboom
    W Hoogendijk
    J H Smit
    P de Jonge
    B W J H Penninx
    [J]. Translational Psychiatry, 2012, 2 : e79 - e79
  • [2] Compliance with antidepressant medication among prison inmates with depressive disorders
    Baillargeon, J
    Contreras, S
    Grady, JJ
    Black, SA
    Murray, O
    [J]. PSYCHIATRIC SERVICES, 2000, 51 (11) : 1444 - 1446
  • [3] Depressive Disorders and Antidepressant Medication Prescribing Patterns in Pregnant Women
    Banken, Joseph
    Manning, Nirvana
    Lowery, Curtis
    [J]. REPRODUCTIVE SCIENCES, 2009, 16 (03) : 304A - 304A
  • [4] Antidepressant medication use and prostate cancer recurrence in men with depressive disorders
    Reina Haque
    Stephanie Reading
    Michael R. Irwin
    Lie Hong Chen
    Jeff Slezak
    [J]. Cancer Causes & Control, 2022, 33 : 1363 - 1372
  • [5] Antidepressant medication use and prostate cancer recurrence in men with depressive disorders
    Haque, Reina
    Reading, Stephanie
    Irwin, Michael R.
    Chen, Lie Hong
    Slezak, Jeff
    [J]. CANCER CAUSES & CONTROL, 2022, 33 (11) : 1363 - 1372
  • [6] Variables influencing antidepressant medication adherence for treating outpatients with depressive disorders
    Lee, Moon-Soo
    Lee, Hwa-Young
    Kang, Seung-Gul
    Yang, Jaewon
    Ahn, Hyonggin
    Rhee, MinKyu
    Ko, Young-Hoon
    Joe, Sook-Haeng
    Jung, In-Kwa
    Kim, Seung-Hyun
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2010, 123 (1-3) : 216 - 221
  • [7] The association of perfectionism with depression, antidepressant medication response and suicidal ideation
    Gul, Elif Sultan
    Yilmaz, Ayseguel
    Berksun, Oguz
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (01): : 48 - 54
  • [8] Functional Connectome Networks Underlying Outcomes of Antidepressant Medication in Major Depressive Disorders
    Korgaonkar, Mayuresh
    Goldstein-Piekarski, Andrea
    Fornito, Alex
    Williams, Leanne
    [J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S104 - S104
  • [9] Association of Plasma Insulin-like Growth Factor-1 With Depressive and Anxiety Disorders, and Antidepressant Medication Use
    Bot, Mariska
    Milaneschi, Yuri
    Penninx, Brenda W. J. H.
    Drent, Madeleine L.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [10] DEPRESSION, ANTIDEPRESSANT MEDICATION, AND CANCER
    BRANDES, LJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1992, 136 (11) : 1414 - 1415